Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Windemuth

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Personalized Medicine|May 26, 2018
Personalizing public healthTheodore R Holford, Andreas Windemuth, Gualberto Ruaño
Pharmacogenomics|March 7, 2006
Designing physiogenomic studiesTheodore R Holford, Andreas Windemuth, Gualberto Ruaño
Drug Discovery Today|August 28, 2017
Structural coverage of the proteome for pharmaceutical applicationsJoseph C Somody, Stephen S MacKinnon, Andreas Windemuth
Current Protocols|November 18, 2021
Proteome-Scale Drug-Target Interaction Predictions: Approaches and ApplicationsStephen Scott MacKinnon, S A Madani Tonekaboni, Andreas Windemuth
Pharmacogenomics|June 8, 2002
How many SNPs does a genome-wide haplotype map require?Richard Judson, Benjamin Salisbury, Julie Schneider, et al.
Atherosclerosis|November 9, 2004
New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individualsRichard Judson, Carlos Brain, Brad Dain, et al.
Pharmacogenomics|November 5, 2003
Genome-wide evaluation of the public SNP databasesRuhong Jiang, Jicheng Duan, Andreas Windemuth, et al.
Clinics in Laboratory Medicine|August 13, 2016
Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of StatinsGualberto Ruaño, Richard Seip, Andreas Windemuth, et al.
Annals of Biomedical Engineering|March 12, 2008
Physiogenomic analysis of localized FMRI brain activity in schizophreniaAndreas Windemuth, Vince D Calhoun, Godfrey D Pearlson, et al.
Human Brain Mapping|December 12, 2007
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICAJingyu Liu, Godfrey Pearlson, Andreas Windemuth, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Personalized Medicine|May 26, 2018
Personalizing public healthTheodore R Holford, Andreas Windemuth, Gualberto Ruaño
Pharmacogenomics|March 7, 2006
Designing physiogenomic studiesTheodore R Holford, Andreas Windemuth, Gualberto Ruaño
Drug Discovery Today|August 28, 2017
Structural coverage of the proteome for pharmaceutical applicationsJoseph C Somody, Stephen S MacKinnon, Andreas Windemuth
Current Protocols|November 18, 2021
Proteome-Scale Drug-Target Interaction Predictions: Approaches and ApplicationsStephen Scott MacKinnon, S A Madani Tonekaboni, Andreas Windemuth
Pharmacogenomics|June 8, 2002
How many SNPs does a genome-wide haplotype map require?Richard Judson, Benjamin Salisbury, Julie Schneider, et al.
Atherosclerosis|November 9, 2004
New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individualsRichard Judson, Carlos Brain, Brad Dain, et al.
Pharmacogenomics|November 5, 2003
Genome-wide evaluation of the public SNP databasesRuhong Jiang, Jicheng Duan, Andreas Windemuth, et al.
Clinics in Laboratory Medicine|August 13, 2016
Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of StatinsGualberto Ruaño, Richard Seip, Andreas Windemuth, et al.
Annals of Biomedical Engineering|March 12, 2008
Physiogenomic analysis of localized FMRI brain activity in schizophreniaAndreas Windemuth, Vince D Calhoun, Godfrey D Pearlson, et al.
Human Brain Mapping|December 12, 2007
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICAJingyu Liu, Godfrey Pearlson, Andreas Windemuth, et al.
Pageof 5